Table 2.
Antibiotics | AB MBCalone (μg/ml) | SM1 (MBCalone = 50 μM) | SM3 (MBCalone = 25 μM) | SM4 (MBCalone = 10 μM) | SM5 (MBCalone = 25 μM) | ||||
---|---|---|---|---|---|---|---|---|---|
AB MBCcombined | SM1 MBCcombined | AB MBCcombined | SM3 MBCcombined | AB MBCcombined | SM4 MBCcombined | AB MBCcombined | SM5 MBCcombined | ||
Ciprofloxacin | 0.0625 | 0.001b | 40b | 0.004b | 15b | 0.004b | 7.5b | 0.004b | 20b |
0.004a | 20a | 0.006a | 10a | 0.006 | 10c | ||||
0.006a | 5a | 0.008a | 5a | ||||||
Erythromycin | 200 | 200c | 50 | 200c | 25c | 200c | 10c | 200c | 25c |
Cefotaxime | 3.2 | 3.2c | 50 | 3.2c | 25c | 3.2c | 10c | 3.2c | 25c |
Nalidixic acid | 16 | 4.8c | 40 | 16c | 25c | 16c | 10c | 16c | 25c |
8c | 30 | ||||||||
Cefeprime | 2 | 0.2a | 20a | 0.4b | 20b | 0.4c | 10c | 2c | 25c |
1.2b | 10b | 0.8b | 15b | 1.6b | 1.25b | ||||
1.6b | 5b | 1.2b | 2.5b | ||||||
Meropenem | 0.2 | 0.04b | 20b | 0.08c | 20c | 0.2c | 10c | 0.2c | 25c |
0.08b | 10b | 0.16c | 15 c | ||||||
0.16b | 5b |
aSynergetic effect (FBC ≤ 0.5; reduction in MBCs superior to 75% for both antibiotic and SM). bAdditive effect (FBC > 0.5 and ≤ 1.0; percentage reduction in MBCs between 50% and 75% for both antibiotic and SM). cIndifferent (FBC > 1.0 and ≤2.0; reduction in MBCs inferior to 50% for both antibiotic and SM). Antibiotic values in μg/ml. SM values in μM. MBC: minimal bactericidal concentration; AB: antibiotic; FBC: fractional bactericidal concentration.